Name: Prognosis of advanced bronchopulmonary cancer (en Inglés)
Price: 1473.67 MXN
Availability: InStock
Author: Kwas, Hamida
ISBN: 9786205964033

Envío gratis

portada Prognosis of advanced bronchopulmonary cancer (en Inglés)

Formato

Libro Físico

Autor

Hamida Kwas

Editorial

Our Knowledge Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.5 cm

Peso

0.14 kg.

ISBN13

9786205964033

Categorías

Cuestiones generales de la medicina

Prognosis of advanced bronchopulmonary cancer (en Inglés)

Hamida Kwas (Autor) · Our Knowledge Publishing · Tapa Blanda

Libro Nuevo

$ 1,473.67

$ 2,456.11

Ahorras: $ 982.44

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 19 de Julio y el Lunes 29 de Julio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Prognosis of advanced bronchopulmonary cancer (en Inglés)"

Introduction: Primary bronchopulmonary cancer represents the leading cause of cancer mortality in men worldwide. Objective: To evaluate the prognosis of patients with locally advanced and metastatic non-small cell lung carcinoma (NSCLC) and to determine prognostic factors at these stages. Methods: Retrospective study including 140 cases of locally advanced and metastatic NSCLC diagnosed in our department between 2003 and 2013. Results: The mean age was 61 10 years with a clear male predominance. The cancer was stage IIIA in 14%, IIIB in 27% and IV in 59%. Survival at 6 months and 1 year was 50-74% and 9-25%, respectively. Survival was significantly longer in patients with stage III cancer, a performance status (PS) of 0 to 1, comorbidities, prolonged time to positive diagnosis, short treatment time, and who received specific antitumor therapy. Conclusion: Prognostic factors for advanced NSCLC are PS, stage, comorbidities, time to management, and specific antitumor therapy.